Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Kit type
1.1.2. Technology
1.1.3. Tested parameters
1.1.4. Micro-organisms
1.1.5. Purpose
1.1.6. End-use
1.1.7. Regional Scope
1.1.8. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Kit type outlook
2.2.2. Technology
2.2.3. Tested parameters
2.2.4. Micro-organisms
2.2.5. Purpose
2.2.6. End-use
2.2.7. Regional outlook
2.3. Competitive Insights
Chapter 3. Biotechnology Reagents & Kits Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Biotechnology Reagents & Kits Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Biotechnology Reagents & Kits: Kit Type Estimates & Trend Analysis
4.1. Biotechnology Reagents & Kits Market: Key Takeaways
4.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Purification Kits
4.3.1. Purification kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Amplification Kits
4.4.1. Amplification kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Detection Kits
4.5.1. Detection kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Isolation Kits
4.6.1. Isolation kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Biotechnology Reagents & Kits: Technology Estimates & Trend Analysis
5.1. Biotechnology Reagents & Kits Market: Key Takeaways
5.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
5.3. LAMP technology
5.3.1. LAMP technology market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. PCR
5.4.1. PCR market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Cell Structure
5.5.1. Cell structure market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Sequencing
5.6.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
5.7. Chromatography
5.7.1. Chromatography market estimates and forecasts, 2018 to 2030 (USD Billion)
5.8. Electrophoresis
5.8.1. Electrophoresis market estimates and forecasts, 2018 to 2030 (USD Billion)
5.9. Flow Cytometry
5.9.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Billion)
5.10. Other technologies
5.10.1. Other technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Biotechnology Reagents & Kits: Tested Parameter Estimates & Trend Analysis
6.1. Biotechnology Reagents & Kits Market: Key Takeaways
6.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
6.3. DNA
6.3.1. DNA market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. RNA
6.4.1. RNA market estimates and forecasts, 2018 to 2030 (USD Billion)
6.5. Enzymes
6.5.1. Enzymes market estimates and forecasts, 2018 to 2030 (USD Billion)
6.6. Proteins
6.6.1. Proteins market estimates and forecasts, 2018 to 2030 (USD Billion)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Biotechnology Reagents & Kits: Micro-organisms Estimates & Trend Analysis
7.1. Biotechnology Reagents & Kits Market: Key Takeaways
7.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Bacteria
7.3.1. Bacteria market estimates and forecasts, 2018 to 2030 (USD Billion)
7.4. Virus
7.4.1. Virus market estimates and forecasts, 2018 to 2030 (USD Billion)
7.5. Fungi
7.5.1. Fungi market estimates and forecasts, 2018 to 2030 (USD Billion)
7.6. Parasites
7.6.1. Parasites market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Biotechnology Reagents & Kits: Purpose Estimates & Trend Analysis
8.1. Biotechnology Reagents & Kits Market: Key Takeaways
8.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
8.3. On-site
8.3.1. On-site market estimates and forecasts, 2018 to 2030 (USD Billion)
8.4. Laboratory
8.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 9. Biotechnology Reagents & Kits: End-use Estimates & Trend Analysis
9.1. Biotechnology Reagents & Kits Market: Key Takeaways
9.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
9.3. Healthcare
9.3.1. Healthcare market estimates and forecasts, 2018 to 2030 (USD Billion)
9.4. Food and Agriculture
9.4.1. Food and Agriculture market estimates and forecasts, 2018 to 2030 (USD Billion)
9.5. Natural Resources and Environment
9.5.1. Natural Resources and Environment market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 10. Biotechnology Reagents & Kits Market: Regional Estimates & Trend Analysis
10.1. Regional Outlook
10.2. Biotechnology Reagents & Kits Market by Region: Key Takeaways
10.3. North America
10.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.3.2. U.S.
10.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.3.3. Canada
10.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4. Europe
10.4.1. UK
10.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.2. Germany
10.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.3. France
10.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.4. Italy
10.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.5. Spain
10.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.6. Denmark
10.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.7. Sweden
10.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.4.8. Norway
10.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.5. Asia Pacific
10.5.1. Japan
10.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.5.2. China
10.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.5.3. India
10.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.5.4. Australia
10.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.5.5. Thailand
10.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.5.6. South Korea
10.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.6. Latin America
10.6.1. Brazil
10.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.6.2. Mexico
10.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.6.3. Argentina
10.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.7. MEA
10.7.1. South Africa
10.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.7.2. Saudi Arabia
10.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.7.3. UAE
10.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
10.7.4. Kuwait
10.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
Chapter 11. Competitive Landscape
11.1. Recent Developments & Impact Analysis, By Key Market Participants
11.2. Market Participant Categorization
11.2.1. Thermos Fisher Scientific
11.2.1.1. Company overview
11.2.1.2. Financial performance
11.2.1.3. Product benchmarking
11.2.1.4. Strategic initiatives
11.2.2. QIAGEN
11.2.2.1. Company overview
11.2.2.2. Financial performance
11.2.2.3. Product benchmarking
11.2.2.4. Strategic initiatives
11.2.3. New England Biolabs
11.2.3.1. Company overview
11.2.3.2. Financial performance
11.2.3.3. Product benchmarking
11.2.3.4. Strategic initiatives
11.2.4. Illumina, Inc.
11.2.4.1. Company overview
11.2.4.2. Financial performance
11.2.4.3. Product benchmarking
11.2.4.4. Strategic initiatives
11.2.5. Agilent Technologies, Inc.
11.2.5.1. Company overview
11.2.5.2. Financial performance
11.2.5.3. Product benchmarking
11.2.5.4. Strategic initiatives
11.2.6. Bio Rad Laboratories
11.2.6.1. Company overview
11.2.6.2. Financial performance
11.2.6.3. Product benchmarking
11.2.6.4. Strategic initiatives
11.2.7. F. Hoffman-La Roche Ltd.
11.2.7.1. Company overview
11.2.7.2. Financial performance
11.2.7.3. Product benchmarking
11.2.7.4. Strategic initiatives
11.2.8. Merck KGaA
11.2.8.1. Company overview
11.2.8.2. Financial performance
11.2.8.3. Product benchmarking
11.2.8.4. Strategic initiatives
11.2.9. Promega Corp.
11.2.9.1. Company overview
11.2.9.2. Financial performance
11.2.9.3. Product benchmarking
11.2.9.4. Strategic initiatives
11.2.10. Takara Bio, Inc.
11.2.10.1. Company overview
11.2.10.2. Financial performance
11.2.10.3. Product benchmarking
11.2.10.4. Strategic initiatives
11.2.11. LGC Ltd.
11.2.11.1. Company overview
11.2.11.2. Financial performance
11.2.11.3. Product benchmarking
11.2.11.4. Strategic initiatives
11.2.12. Toyobo Co. Ltd
11.2.12.1. Company overview
11.2.12.2. Financial performance
11.2.12.3. Product benchmarking
11.2.12.4. Strategic initiatives